Latest News
-
Hindustan Zinc to Persist in Demerger Discussions with Government, Says CEO -
8 Tata Group Stocks To Buy That Will Pay Dividends Soon, Q4 In Focus; Are You Invested? -
Gold Prices In US: Yellow Metal Rates Surge Amid Escalating Tensions In Middle East; Hit Record High -
Jio Financial Services Sees 80% YoY Decline In Q4 Net Profit, Net Interest Income Dives 70% -
Rs 25/Share Dividend Payout: Multibagger Small Cap Tata Stock Declares 52.6% Jump In Q4 PAT -
Wipro Q4 Results: Cons PAT Up 5% QoQ To Rs 2,834.6 Crore, Revenue Guidance Weaker Than Estimates -
How To Apply Your Voter ID Card Online: Quick Guide For Indian Citizens -
Emmforce Autotech IPO Debut April 23: Issue Size, Price Band, Check Details? -
1:5 Stock Split: PSU Bank Fixes Record Date For First Ever Stock Split; Buy For Rs 650-680 Targets -
Closing Bell: Market Stages Smart Recovery, Sensex & Nifty Snap 4-Day Losing Streak Led By HDFC Bank
MedPlus Health Lists At 31% Premium To Issue Price Of Rs. 796
MedPlus as reflected by its GMP and amid improved sentiments listed at Rs. 1015 on the BSE. On the NSE, the stock opened at a price of Rs. 1040, a 31 percent premium in comparison to the issue price of Rs. 796 per share.
The market sentiment have comparatively improved as Omicron related worries have eased and the GMP of the stock a day prior to the listing has been Rs. 180 as per ipowatch.in. While as per another publication the GMP has gone down to Rs. 90-100 apiece, a premium of 10-12 percent in comparison to its issue price of Rs. 796. So, the listing price can be likely between Rs. 886-896 per share.
The premium listing anticipated for the issue is owing to strong financial as well as business model.
The issue of Med Plus that ran between December 13-15 saw huge investor interest with bids received about 53 times.
The Rs 1,398 crore IPO consisted of a Rs 600 crore fresh issue and an offer for sale by selling stake of Rs 798.3 crore.
GoodReturns.in
